XBiotech Inc.
XBIT
$2.32
-$0.09-3.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.01M | -1.76M | -10.88M | -10.51M | -5.02M |
| Total Depreciation and Amortization | 427.00K | 439.00K | 442.00K | 439.00K | 439.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.23M | -2.97M | 3.05M | 4.73M | -342.00K |
| Change in Net Operating Assets | 96.00K | -1.70M | 677.00K | -1.20M | -927.00K |
| Cash from Operations | -4.26M | -5.99M | -6.72M | -6.54M | -5.85M |
| Capital Expenditure | -110.00K | -51.00K | -94.00K | -84.00K | -338.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -110.00K | -51.00K | -94.00K | -84.00K | -338.00K |
| Total Debt Issued | -- | -- | -- | 250.00K | 0.00 |
| Total Debt Repaid | 0.00 | 0.00 | -10.25M | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 33.00K | 64.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 0.00 | -10.25M | 283.00K | 64.00K |
| Foreign Exchange rate Adjustments | -1.20M | 3.08M | 284.00K | -4.10M | 707.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.57M | -2.96M | -16.78M | -10.44M | -5.41M |